Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;37(7):1701-6.
doi: 10.1007/s00268-013-2037-2.

Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?

Affiliations

Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?

Joakim Crona et al. World J Surg. 2013 Jul.

Abstract

Background: Metastases from neuroendocrine tumors (NETs) to the breast have been described as a rare phenomenon. Presentation, imaging results, and cytopathologic findings of these tumours may closely mimic those of a mammary carcinoma.

Methods: This study was a retrospective review of 661 patients with metastatic NETs, of whom 280 were females, treated at Uppsala University Hospital, Uppsala, Sweden. Patients with pathological breast lesions were identified. Histopathological slides from available NET breast lesions were analyzed for mammary carcinoma and neuroendocrine markers.

Results: We have identified 20 female patients with NET metastases to the breast, 11/235 with small intestinal NETs, 8/55 with lung NETs, and 1/6 with thymic NETs. There were no male patients with NET metastatic to the breast. Four patients had their breast lesion initially diagnosed as mammary carcinoma. Retrospectively, these lesions showed negative staining for mammary carcinoma markers.

Conclusions: Metastases to the breast from neuroendocrine tumors may be more common than previously thought. Patients with a lesion to the breast and symptoms typical for NET may benefit from additional histopathological investigation, because NET metastases and mammary carcinoma have different immunohistochemical profiles.

PubMed Disclaimer

References

    1. Histopathology. 2011 Oct;59(4):619-30 - PubMed
    1. Gynecol Oncol. 2007 Jul;106(1):65-8 - PubMed
    1. Ann Saudi Med. 2009 Jul-Aug;29(4):320-1 - PubMed
    1. J Obstet Gynaecol Res. 2010 Jun;36(3):567-71 - PubMed
    1. Breast. 2003 Aug;12(4):251-7 - PubMed

Publication types

Substances

LinkOut - more resources